Cantor Fitzgerald Initiates Flex Pharma At Buy

by Monica Gerson, Benzinga Staff Writer

February 23, 2015 8:14 AM | 12 seconds read | Make a Comment

Analysts at Cantor Fitzgerald initiated coverage on

Flex Pharma, Inc.FLKS

with a Buy rating. The target price for Flex Pharma is set to $22. Flex Pharma shares rose 1.52% to close at $14.71 on Friday.

Posted In: Initiation Analyst Ratings Cantor Fitzgerald

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.